The ESCMID Fungal Infection Study Group (EFISG) is dedicated to fostering a strong network and promoting knowledge sharing through engaging educational activities, insightful conferences, and impactful publications. It's goal is to boost global awareness and management of fungal diseases (FDs) among everyone, from healthcare professionals and researchers to the general public. FDs are a growing threat to public health, driven by a shifting epidemiology, increasing resistance, and limited available treatments. It's within this context that the EFISG steps up as a key global player. They have been at the forefront, advising the World Health Organization (WHO) on prioritising fungal pathogens, and supporting efforts to enhance diagnostics, develop better antifungal treatments, and strengthen resistance surveillance, all in collaboration with international mycology societies.